In an ICC dispute, CRA was retained by respondent regarding the renegotiation of price in a supply agreement for a pharmaceutical sold in Japan. In expert reports and testimony, CRA evaluated the adequacy of returns made by respondent with request to development and commercialization of the product for the Japanese market.
Looking ahead to 2026: Trends and expectations for International Arbitration
Across both investor-state and commercial cases, quantum debates have recently turned on attribution under concurrent shocks, the interaction of contract terms...